Prostate Cancer: What Questions Should You Be Asking Your Doctor?

(HealthDay News) — For men with high-risk biochemically recurrent prostate cancer, olaparib monotherapy yields good prostate-specific antigen (PSA) response rates, especially among those with BRCA2, according to a study published online Aug. 22 in JAMA Oncology. Catherine H. Marshall, M.D., from read more about This Clinical Trial Showed Promise in Recurrent Prostate Cancer Patients

Finding out you have cancer can be scary and confusing. Luckily, doctors and researchers are working hard to find new ways to beat all types of cancers, including prostate cancer.  The prostate is a small gland found only in men. read more about Prostate Cancer Clinical Trials: What Black Men Need to Know

Preliminary clinical research findings by the University of Alberta indicate that PET/CT imaging could replace the standard MRI in the detection and prediction of the spread of prostate cancer.   The research, led by Dr. Adam Kinnaird, found PET/CT scan imaging read more about This Clinical Trial Could Change How Prostate Cancer Is Detected in Black Men